Molecular PsychiatryNeurosciencePeer-reviewed journal article
Neuronal HDAC9: A key regulator of cognitive and synaptic aging, rescuing Alzheimer's disease-related phenotypes
Yun LeiiD, Yuting CheniD, Ming‐Lei GuoiD, Florikaben Patel, Yu BaiiD, Brandee M. S. S. GooiD, Quansheng DuiD, Neal L. WeintraubiD, Xin‐Yun LuiD
Abstract
Epigenetic regulation is a key determinant of the aging process, and its dysregulation contributes to cognitive aging and increased vulnerability to Alzheimers disease (AD). As major regulators of epigenetic processes, histone deacetylases (HDACs) have emerged as potential therapeutic targets for cognitive enhancement in neurodegenerative diseases. However, the distinct roles of individual HDAC isoforms remain to be defined. Here, we report that HDAC9 is specifically expressed in neurons of human and mouse brains, and its expression declines with age. HDAC9 deficiency impairs cognitive function and synaptic plasticity in young mice. Selective deletion of HDAC9 in hippocampal CA1 neurons also induces cognitive impairment. In contrast, overexpression of HDAC9 in forebrain glutamatergic neurons preserves cognitive function in aged mice. Moreover, HDAC9 is also downregulated in the brain of AD mouse models, whereas neuronal overexpression of HDAC9 alleviates AD-related cognitive and synaptic deficits and reduces A{beta} deposition. Together, these findings suggest neuronal HDAC9 is necessary and sufficient for maintaining cognitive and synaptic functions in the context of aging and AD.
- Citations
- 4
- FWCI
- 8.27
- Field percentile
- top 3%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Enhancing Adult Neurogenesis Rescues Hippocampal Cognitive Functions in an Alzheimer's Mouse Model
Chi‐Chieh Lee, Federico Calegari·bioRxiv·Mar 25, 2026
- Epigenetic derepression of H3K9me3 mitigates Alzheimer-related pathology and improves cognition via immunomodulation and Vgf induction
Dieu-Trang S. Fuchs, Jean‐Philippe Vit, … Maya Koronyo‐Hamaoui·bioRxiv·Oct 15, 2024
- ACSS2 upregulation enhances neuronal resilience to aging and tau-associated neurodegeneration
Naemeh Pourshafie, Desi C. Alexander, … Shelley L. Berger·Proceedings of the National Academy of SciencesPeer-reviewed·Jan 9, 2026
- Exifone is a Potent HDAC1 Activator with Neuroprotective Activity in Human Neuronal Models of Neurodegeneration
D. Patnaik, P.-C. Pao, … S. J. Haggarty·bioRxiv·Mar 2, 2020
- Histone acetylation in an Alzheimer's disease cell model promotes homeostatic amyloid-reducing pathways
Daniel C. Xu, Hanna Sas‐Nowosielska, … Shelley L. Berger·bioRxiv·Sep 18, 2023
- Reinforced Hippocampus-Accumbens pathway marks a shift towards cognitive decline in aging
Aurore Ribera, Brenda Fernandes-Dias, … Paula A. Pousinha·bioRxiv·Jan 22, 2026